The global prevalence of obesity has increased steadily in recent years. Waist circumference (WC) reflects body composition better than body mass index. The Korean Society for the Study of Obesity released the 2018 Obesity Fact Sheet to address the incidence of obesity-related comorbidities according to WC levels. Methods: Data from the Korean National Health Insurance Service health examination database from 2009 to 2016 were analyzed. Abdominal obesity was defined as a WC ≥90 cm in men and ≥85 cm in women. Incidence rates of comorbidities and all-cause mortality rates were calculated after standardizing by age and sex based on the 2010 census. Results: From 2009 to 2015, the incidence rates of type 2 diabetes mellitus, hypertension, myocardial infarction, and ischemic stroke increased both in men and women. Individuals with the lowest WC levels had the highest all-cause mortality rates followed by those with the highest WC levels in men, women, and the total population. The incidence rates of total cancer increased as WC levels escalated between 2009 and 2016. In men, the incidence rates of colorectal, prostate, and liver cancers increased as WC levels increased. The incidence rates of thyroid, colorectal, and stomach cancers increased as WC levels rose in women. In addition, medical expenses continuously increased as WC increased in both men and women. Conclusion: Based on the 2018 Obesity Fact Sheet, strategies for reducing the abdominal obesity and related comorbidities and medical expenses are a public health priority.
INTRODUCTION
With its increased prevalence in recent decades, obesity is considered to be a global pandemic. In 2016, ≥ 39% of adults were overweight and ≥ 13% were obese worldwide. 1, 2 In Korea, the prevalence of obesity and abdominal obesity also increased steadily from 2009 to 2015. In 2015, the prevalence of obesity and abdominal obesity was 32.4% and 20.8%, respectively. 3 The increasing prevalence of obesity has led to a large health and economic burden worldwide because excess weight gain causes mortality and various chronic diseases such as type 2 diabetes mellitus, cardiovascular diseases (CVDs), and cancers. 4 Although body mass index (BMI) is recognized as a clinical and epidemiologic tool for assessing obesity, BMI does not reflect body composition accurately; the same BMI range may be associated with substantial variations in total and visceral adiposity. 5 Moreover, several studies suggest that BMI may not be a satisfactory predictor of mortality risk. 6, 7 Obesity-related comorbidities are more closely related to abdominal adiposity than with total body fat quantity. 8 
METHODS

Database and population
This study was based on the national health examination database provided by the Korean National Health Insurance Service (NHIS). The NHIS is a nonprofit and single-payer system managed by the Korean NHIC. The NHIS supplies universal medical coverage for all Korean residents and reimburses healthcare providers based on a fee-for-service system. As the Korean NHIC provides health examinations at least every 2 years for all insured peo- 
Definitions of obesity and abdominal obesity
Participants' height, body weight, and WC were measured. BMI was calculated by dividing body weight in kilograms by the square of the height in meters. Obesity was defined as a BMI ≥ 25 kg/m 2 in accordance with the Asia-Pacific criteria of the World Health Organization guidelines. 11 Abdominal obesity was defined as a WC ≥ 90 cm in men and ≥ 85 cm in women in accordance with the definition of the KSSO. 12, 13 Six levels of WC generated with 5-cm increments were categorized: level 1, < 80 cm in men and < 75 cm in women; level 2, 80-85 cm in men and 75-80 cm in women; level 3, 85-90 cm in men and 80-85 cm in women; level 4, 90-95 cm in men and 85-90 cm in women; level 5, 95-100 cm in men and 90-95 cm in women; and level 6, ≥ 100 cm in men and ≥ 95 cm in women.
Definition of comorbidities
Type 2 diabetes mellitus was defined as a fasting plasma glucose level of ≥ 126 mg/dL or at least one claim per year for prescription of antidiabetic medication under ICD-10 codes E11-E14. 14 Ischemic stroke was defined as an event-related hospitalization un-der ICD-10 code I63 or I64 and claims for brain magnetic resonance imaging or computed tomography. Cancer was defined as ICD-10 codes for cancers and registration code (V193) for cancers. Total cancer referred to all cancers with the ICD-10 "C" code.
Annual medical expenses
We used the NHIS-National Sample Cohort between 2010 and 2015 to assess the annual medical expenses per patient. The annual medical expenses were estimated using a two-part model after adjusting for age and comorbidities (type 2 diabetes mellitus, hypertension, myocardial infarction, dyslipidemia, and ischemic stroke).
In this analysis, we excluded patients with cancer, human immunodeficiency virus, hemophilia, third degree burns, transplanted or- Incidence rates (IRs) per 1,000 person-years are presented standardized for age and sex based on the 2010 census of the Korean population. Waist circumference was categorized by 5-cm increments (level 1-6). Level 1, < 80 cm in men and < 75 cm in women; Level 2, 80-85 cm in men and 75-80 cm in women; Level 3, 85-90 cm in men and 80-85 cm in women; Level 4, 90-95 cm in men and 85-90 cm in women; Level 5, 95-100 cm in men and 90-95 cm in women; Level 6, ≥ 100 cm in men and ≥ 95 cm in women. 
Statistical analysis
The incidence rates of comorbidities and all-cause mortality per 1,000 person-years (PY) are presented standardized for age and sex using the 2010 census of the Korean population. The incidence rate of cancer per 100,000 PY is presented standardized for age and sex using the 2010 census of the Korean population. All statistical analyses were conducted using SAS version 9.4 (SAS Institute Inc., Cary, NC, USA). 
RESULTS
WC and incidence of chronic diseases
WC and incidence of cancers
The incidence rates of total cancer increased as WC levels escalated between 2009 and 2016 ( Fig. 2) . In the level 6 WC of total, men, and women populations, total cancer occurred in 742.6, 781.1, and 705.8 individuals per 100,000 PY, respectively. Table 2 presents the incidence rates of five major types of cancer according to WC levels in men and women. In men, the incidence rates of colorectal, prostate, and liver cancers increased as WC levels increased. The incidence rates of thyroid, colorectal, and stomach nal obesity showed greater incidence of lymphoma as well as renal, thyroid, bladder, colorectal, testicular, liver, biliary, prostate, and skin cancers than men without abdominal obesity. In women, individuals with abdominal obesity had increased incidence of uterine, renal, liver, biliary, bladder, nervous system, pancreatic, and colorectal cancers, leukemia, and lymphoma than those without abdominal obesity. Particularly, men with abdominal obesity showed 1.53 and 1.46 times greater incidence of renal and thyroid cancers, respectively, than those without abdominal obesity; women with abdominal obesity showed 1.56 and 1.33 times greater incidence of uterine corpus and renal cancers, respectively, than those without abdominal obesity. the BMI increased to 35 kg/m 2 in the total population and men and to 30 kg/m 2 in women. Above those points, the medical expenses tended to decrease slightly with severe obesity. However, the medical expenses continuously increased as WC increased in both men and women. In all age groups older than 35 years, the annual medical expenses continuously increased as BMI and WC in-cancers increased as WC levels rose in women. Fig. 3 shows the incidence rate ratio for cancers in individuals with abdominal obesity compared to those without abdominal obesity. Men with abdomi- 
Obesity parameters and medical expenses
DISCUSSION
In this study, we found that the incidence of obesity-related comorbidities including type 2 diabetes mellitus, hypertension, myocardial infarction, and ischemic stroke has increased with increasing WC levels from 2009 to 2015. From 2009 to 2016, incidence of total cancer, colorectal, prostate, and liver cancers in men and thyroid, colorectal, and stomach cancers in women increased with increasing WC levels. The mortality rate from all causes was the highest in individuals with the lowest WC level but followed by the highest level of WC. In addition, the annual medical expenses constantly increased with WC levels in individuals aged ≥ 35 years. The results from the 2018 Obesity Fact Sheet suggest that greater levels of WC are associated with higher incidence of chronic diseases and all-cause mortality rates, and management for achieving appropriate WC is essential for reducing the incidence of chronic diseases and mortality rate.
Both hypertension and type 2 diabetes mellitus are associated 15 In the 2017 Obesity Fact Sheet, higher incidences of hypertension and type 2 diabetes mellitus were observed as BMI levels increased. 3 In addition to these findings, present findings suggest that incidences of both diseases are associated with increasing WC levels as well as increasing BMI levels in Koreans. Previous studies have reported that WC was a strong predictor for hypertension incidence independent of BMI. [16] [17] [18] Consistent with previous evidence, our study showed that increased WC was associated with increased incidence of hypertension. A number of mechanisms are associated with this increased incidence of hypertension. Visceral adipose tissue produces proinflammatory cytokines, angiotensino-gen, cortisol, leptin, and reactive oxygen species; activates the sympathetic nervous system and the renin-angiotensin system; and promotes insulin resistance. [19] [20] [21] WC is considered to be an important predictor for the development of type 2 diabetes mellitus. 22 A significant proportion of Asian adults have normal BMI at the time of type 2 diabetes mellitus diagnosis, and WC is strongly correlated with type 2 diabetes mellitus in European and Asian adults. 15, 23 Our findings support the positive association between WC and incidence of type 2 diabetes mellitus in East Asians. Visceral fat excess is associated with decreased insulin sensitivity and results in poor glycemic control that may be further linked to the development of diabetes. 24 Although the association of BMI with CVDs and mortality has been intensively investigated, the correlations between CVD incidence and indices of abdominal obesity appear to be closer than those of BMI. 25 Several studies have revealed that abdominal obesity measures are superior to BMI in predicting the risk of CVDs. 26 Moreover, excessive fat mass in the body, rather than excessive body weight, is the leading cause of the increased risk of CVDs among obese individuals. 27 Our study provides additional evidence on the positive association between WC and incidence of myocardial infarction and ischemic stroke. Abdominal obesity may contribute to CVDs via various pathways related to oxidative stress, inflammation, steroid hormones, free fatty acids, and altered production and function of adipocyte-derived hormones. 28 Recent imaging studies of cardiac metabolism conducted in large cohort studies have shown that hyperplastic visceral fat exceeds its storage capacity and is oversaturated, resulting in a spillover of lipids contributing to metabolic and cardiac abnormalities. 29 . A recent meta-analysis with strong evidence consistently reported that 11 cancers are associated with adiposity. 31 Because of our use of WC as the marker for adiposity, our findings not only support but also provide additional evidence to these previous findings.
There are some limitations to our study. First, discrepancies in disease diagnosis may have occurred because we used operational definitions for the definition of each disease. Second, we assessed incidence rates of diseases and all-cause mortality rate standardizing by age and sex; however, we could not account for the various confounding factors for each disease. However, this study was rep-resentative of the entire Korean population and evaluated mortality rate and the incidence rates of substantial outcomes including type 2 diabetes mellitus, hypertension, CVDs, and cancers according to WC categories.
In conclusion, based on information from the 2018 Obesity Fact Sheet, higher WC levels are associated with increased mortality and incidence of chronic diseases as well as higher medical expenses. Developing policies to reduce abdominal obesity for the prevention of abdominal obesity-related comorbidities and decrease in the medical expenses is a public health priority.
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